This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
10/22/2024
Good morning, everyone, and welcome to this presentation of our Q3 report 2024. And ours means Bravida. And as usual and always, it's myself, Mattias, CEO, who will take you through this presentation together with... Åsa Neeming, CFO. So again, warm welcome to this presentation. And we start directly with the Q3 highlights. Really, really strong cash conversion. Cash flow improves a lot in the quarter, which is fantastic. We have flat growth, which is pretty much as expected as earlier communicated. Service is growing with 8%. Organic growth is minus 3%. The order intake is down with 12%, mainly because we are very strict in our project selection, but also, of course, due to the soft market demands we see, especially in Finland and the south part of Sweden. Order backlog is still on very high levels. We are comfortable with the size and the margins in the order backlog. There are some differences if we compare some geographies, some regions, branches, etc. But that is always the case. Overall, a very strong backlog with good margins. The order backlog decreases during the quarter except for Denmark. The margin is around or is 4.5%. If we adjust for some one-off cost, we are actually at 4.8 compared to 5.4 last year. And that is primarily affected by the operational changes we're doing in Denmark and the weak demand we see in the south part of Sweden. Happy to see that both Finland and Norway are improving the margins and also that we are having a very good performance in the north part of Sweden and stable performance in the Stockholm area of Sweden as well. We have some costs for changes in the organization, one-offs, both in Denmark and south part of Sweden. They are adding up to 19 million in one-offs costs for the quarter, and that is... approximately 0.3% units on the margin. Norway's margin is up to 5.7% and that is including the big acquisition of Tunisvet that we did last year and the Tunisvet acquisition is going due to the plan as well. So positive development in Finland and also the same in Finland. So very well done from the Finnish and the Norwegian organizations. Strong cash flow, as I mentioned in the beginning, 193 million compared to minus 212 last year. An improvement with around 400 million. And cash conversion at 134%. Fantastic numbers. And also happy to say that the accidents actually leading to sick leave is declining as well. We're improving that number with 17%. The bridge, if we look at the sales last year compared to this quarter, we see, as expected, negative organic growth around 200 million minus.
We are adding some 400 million from M&A, and then we have some currency effects as well, minus 148 million, and that takes us to the 6,500,000. 75 million in sales.
continue to grow from acquisitions, a small drop in the organic, but I think that is showing stability. We also said that 8% growth is coming from the service business, which creates good stability in these market conditions, of course. If we look at the EBITDA, 4.5% this year compared to 5.4%, improved margin in Finland and Norway, as I said. We also communicated earlier this year that we will struggle the first three quarters in Denmark with the margin, and that is also the case. If we adjust for the one-offs in Denmark, we have black numbers even in the third quarter. And from now on and going forward, we will see an improvement in the margin in the Danish business as well. Cost efficiency measures is done.
You're reading a preview of the BRAV.ST Q3 2024 earnings call.
Free account.
